Skip to main content

and
  1. No Access

    Article

    Comparison of three different methods for radiolabelling human activated T lymphocytes

    One approach in the treatment of ovarian cancer MOv18/anti-CD3 (biMAb OC/TR), which recognizes a 38-kDa glycoprotein expressed on ovarian carcinomas and the CD3 T cell receptor. However, little is known about ...

    Carlo Botti, Donatella R. M. Negri, Ettore Seregni in European Journal of Nuclear Medicine (1997)